CervoMed Inc. Debt Securities, Available-for-sale, Amortized Cost
CervoMed Inc. (CRVO) had Debt Securities, Available-for-sale, Amortized Cost of $2.48 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Credit Losses
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-08-07
- 2026-06-30: Debt Securities, Available-for-sale, Amortized Cost $2.48M.
- 2026-03-31: Debt Securities, Available-for-sale, Amortized Cost $4.98M.
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost $12.62M.
- 2025-09-30: Debt Securities, Available-for-sale, Amortized Cost $17.85M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2026-06-30 | $2.48M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $4.98M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $12.62M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $17.85M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $25.21M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $24.72M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $29.87M 10-K · filed 2026-03-13 |
| 2024-09-30 | $38.79M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $40.91M 10-Q · filed 2024-08-09 |
| 2023-06-30 | $12.44M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $2.99M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $12.44M 10-Q · filed 2023-05-15 |
| 2022-09-30 | $19.36M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $22.66M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $22.73M 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |